三维配准多参数磁共振成像评估前列腺癌局灶治疗
本研究开发了前列腺MRI三维可变形配准软件平台,对10例接受局灶消融治疗的患者在术前、术后1周和6个月行MRI,以刚性配准为参照评估配准精度。结果显示可变形变换将消融区对齐精度提高2.9 mm(最大6.25 mm),较刚性方法改善500%(P=.001),提示该方法能校正消融部位变形,可能有助于图像引导随访活检的靶向定位。
要点
- 术后前列腺体积平均缩小6.49 cc(P=.017),配准需校正腺体变形。
- 可变形配准将消融区对齐精度提高2.9 mm(最大6.25 mm),较刚性方法改善500%(P=.001)。
- 可变形变换映射的消融区Dice差异在消融部位显著高于全腺体(P=.04)。
核心结论
- 可变形变换能校正消融部位变形,基于术前与随访MRI互信息计算的配准在局灶治疗前后MRI中似乎是准确的,可能改善图像引导随访活检的靶向定位。
研究设计与样本
- 研究论文:开发三维可变形配准软件平台,应用于10例接受局灶消融治疗的前列腺癌患者,MRI于术前、术后1周和6个月进行,以刚性配准为参照评估配准精度和精确度。
关键影像表现/征象
- 术后前列腺体积显著缩小,平均缩小6.49 cc(P=.017)。
- 基于120对MRI切片互信息的可变形变换将消融区(从术后1周增强图像分割)对齐到术后6个月T2加权图像,精度提高2.9 mm(最大6.25 mm)。
- 可变形方法较刚性方法改善500%(P=.001),经体积校正。
- 可变形变换映射的消融区Dice差异在消融部位显著高于全腺体(P=.04)。
临床应用与阅片要点
- 作者认为,该方法能在三维空间定位既往消融组织,可能改善局灶治疗协议中图像引导随访活检的靶向定位。
局限性
- 原文为初步分析,样本量为10例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aimed to assess a novel method of three-dimensional (3D) co-registration of prostate magnetic resonance imaging (MRI) examinations performed before and after prostate cancer focal therapy.
MATERIALS AND METHODS: We developed a software platform for automatic 3D deformable co-registration of prostate MRI at different time points and applied this method to 10 patients who underwent focal ablative therapy. MRI examinations were performed preoperatively, as well as 1 week and 6 months post treatment. Rigid registration served as reference for assessing co-registration accuracy and precision.
RESULTS: Segmentation of preoperative and postoperative prostate revealed a significant postoperative volume decrease of the gland that averaged 6.49 cc (P = .017). Applying deformable transformation based on mutual information from 120 pairs of MRI slices, we refined by 2.9 mm (max. 6.25 mm) the alignment of the ablation zone, segmented from contrast-enhanced images on the 1-week postoperative examination, to the 6-month postoperative T2-weighted images. This represented a 500% improvement over the rigid approach (P = .001), corrected by volume. The dissimilarity by Dice index of the mapped ablation zone using deformable transformation vs rigid control was significantly (P = .04) higher at the ablation site than in the whole gland.
CONCLUSIONS: Our findings illustrate our method's ability to correct for deformation at the ablation site. The preliminary analysis suggests that deformable transformation computed from mutual information of preoperative and follow-up MRI is accurate in co-registration of MRI examinations performed before and after focal therapy. The ability to localize the previously ablated tissue in 3D space may improve targeting for image-guided follow-up biopsy within focal therapy protocols.
引用
- Orczyk C, Rosenkrantz AB, Mikheev A, et al. 3D Registration of mpMRI for Assessment of Prostate Cancer Focal Therapy. Acad Radiol. 2017. PMID: 29122471. doi:10.1016/j.acra.2017.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。